These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
822 related articles for article (PubMed ID: 20581680)
21. A transient neonatal myasthenic syndrome with anti-musk antibodies. Niks EH; Verrips A; Semmekrot BA; Prick MJ; Vincent A; van Tol MJ; Jol-van der Zijde CM; Verschuuren JJ Neurology; 2008 Apr; 70(14):1215-6. PubMed ID: 18378885 [No Abstract] [Full Text] [Related]
22. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395 [TBL] [Abstract][Full Text] [Related]
23. Transmission of maternal muscle-specific tyrosine kinase (MuSK) to offspring: report of two cases. Murray EL; Kedar S; Vedanarayanan VV J Clin Neuromuscul Dis; 2010 Dec; 12(2):76-9. PubMed ID: 21386774 [TBL] [Abstract][Full Text] [Related]
24. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586 [TBL] [Abstract][Full Text] [Related]
25. Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis. Lee JY; Min JH; Han SH; Han J Neuromuscul Disord; 2017 Jul; 27(7):655-657. PubMed ID: 28495046 [TBL] [Abstract][Full Text] [Related]
26. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Vincent A; Leite MI Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434 [TBL] [Abstract][Full Text] [Related]
27. [Myasthenia gravis induced by autoantibodies against MuSK]. Shigemoto K; Konishi T; Ohta M Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361 [TBL] [Abstract][Full Text] [Related]
28. Different characteristic phenotypes according to antibody in myasthenia gravis. Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384 [TBL] [Abstract][Full Text] [Related]
29. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981 [TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis. Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794 [TBL] [Abstract][Full Text] [Related]
38. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034 [TBL] [Abstract][Full Text] [Related]